Global Economy Podcasts
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Global Economy Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Tuesday recap

NewsDealsSocialBlogsVideosPodcasts
HomeBusinessGlobal EconomyPodcastsWar in Iran, Healthcare Resurgence & Isa Changes: The Companies and Markets Show
War in Iran, Healthcare Resurgence & Isa Changes: The Companies and Markets Show
Euro StocksGlobal EconomyHealthcarePersonal Finance

The Companies and Markets Show (Investors’ Chronicle)

War in Iran, Healthcare Resurgence & Isa Changes: The Companies and Markets Show

The Companies and Markets Show (Investors’ Chronicle)
•March 6, 2026•40 min
0
The Companies and Markets Show (Investors’ Chronicle)•Mar 6, 2026

Why It Matters

Understanding the geopolitical shock’s impact on energy markets and inflation helps investors gauge short‑term risks and potential defence‑sector opportunities. The healthcare revival signals a possible shift in market momentum, offering a timely investment theme as investors reassess sector allocations. Meanwhile, upcoming ISA changes could affect millions of savers, making the episode’s financial guidance especially relevant.

Key Takeaways

  • •Iran conflict pushes Brent up 15% and gas 60%+.
  • •European gas prices surge 75%, tightening winter storage.
  • •Defense stocks mixed; Europe gains, US contractors flat.
  • •Healthcare valuation gap narrows, earnings upgrades spark momentum rotation.

Pulse Analysis

The sudden US‑Israel strike on Iran has sent shockwaves through global energy markets. Brent crude jumped roughly 15% while European spot gas spiked over 70%, reflecting the strategic importance of the Strait of Hormuz and recent attacks on Qatar’s LNG hub and Saudi refineries. With winter storage already at its lowest since 2022, higher fuel costs are feeding back into inflation expectations, prompting analysts to revise down the likelihood of imminent rate cuts in the UK and the Eurozone. This price turbulence underscores how quickly geopolitical flashpoints can reshape commodity curves and monetary policy outlooks.

In the defense arena, the market response has been uneven. European defense giants such as BAE Systems saw share price gains as governments reassess security budgets, whereas major U.S. contractors like Lockheed Martin and Raytheon posted little movement. The disparity stems from Europe’s more immediate exposure to the Hormuz disruption and its recent pledges to boost defence spending, contrasted with a U.S. political environment where any substantial budget increase must navigate a contentious congressional landscape. Nonetheless, the war has reignited discussions about long‑term capacity building, with U.S. officials hinting at a potential 50% rise in defence outlays by 2027, even as the timing remains uncertain.

Meanwhile, the healthcare sector is emerging from a pandemic‑induced slump. A 20% valuation gap between healthcare indices and broader market benchmarks has begun to close as post‑COVID operational restructurings bear fruit. Companies that accelerated earnings upgrades in 2022‑23 are now delivering stronger margins, prompting a classic sector‑rotation play. Academic research on momentum investing supports the notion that capital will flow from over‑valued tech names into undervalued, lower‑risk assets like healthcare. As fund flows return and earnings trajectories improve, investors are positioning healthcare as the next defensive outperformer, making it a focal point for portfolios seeking both stability and upside in a volatile macro environment.

Episode Description

It’s another day chock-full of company results, albeit market attention is understandably still focused elsewhere given the events in the Middle East over the past week. 

So today, we too will be discussing the implications of the US/Israel war with Iran. Mike Fahy is here to talk about energy, defence, and the implications for the UK and European economies. 

After that, we turn to our big read of the week. The healthcare sector has typically been seen as a port in a storm during troubled times, and after a tough few years there had been signs of a revival even prior to the latest nerves. Julian Hofmann will dive into the detail and ask whether this momentum can continue.

Finally, next week marks the publication of our annual Isa special. With big reforms on the way for these popular savings accounts, personal finance editor Holly McKechnie joins us to discuss what’s happening, as well as outlining some practical steps listeners can take to meet their savings goals.

Timestamps:

00:00: Intro

01:06: War in Iran

13:32: Healthcare resurgence

26:05: Isa changes

Find out more:

‘Operation Epic Fury’ creates more noise for defence shares

Read all the latest stocks & shares news and analysis here

How to invest in the healthcare revival

Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities.

Investors' Chronicle is a service by the Financial Times.

Hosted on Acast. See acast.com/privacy for more information.

Show Notes

0

Comments

Want to join the conversation?

Loading comments...